PTSD-SUD: Latest Developments

Three presenters will discuss new delopments in the treatment of PTSD-SUD.

Kathleen Brady, ast president of ISAM, is a prominent leader in the substance abuse field at a national and international level. She has had a particular focus on the area post-traumatic stress disorder in substance users. She will discuss new undersaning of the neurobiology of PTSD and developments in the treatment of PTSD and SUD, including doxazosin, oxytocin, and TMS (trans magnetic stimulation).

Anil Thomas of NYU Langone will be presenting the latest cutting edge research about the developments of voice recognition and blood biomarker technology that may advance the physiological and molecular profiling of PTSD patients and that may assist addiction physicians in identifying and treating patients with PTSD and co-occurring addictions.  This exciting  current research is spearheaded by the Chair and Distinguished Professor of Psychiatry at NYULangone School of Medicine - Dr. Charles Marmar.

Greg Bunt will describe developments in integrated residential treatment for patients with addictions and co-occuring PTSD. Collaboration with academic centers and governmental agencies have provided those with PTSD and addictions - biopsychosocial treatment continuum of care models needed for full rehabilitation and recovery.